Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Acrocapitofemoral dysplasia is a recently delineated skeletal dysplasia, characterized clinically by short stature of variable degrees with short limbs, brachydactyly and narrow thorax.
Features include always present findings: Brachydactyly, Short stature, Short femoral neck, and Broad nail and others; and common findings: Excessive inward curve of the lower back (lumbar hyperlordosis), Narrow chest, Cupped ribs, and Radial bowing. 46 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 9 | Short femur, Short femoral neck, Excessive inward curve of the lower back (lumbar hyperlordosis) |
IHH encodes Indian hedgehog signaling molecule (411 aa). Plays a role in embryonic morphogenesis; it is involved in the regulation of endochondral skeleton formation, and the development of retinal pigment epithelium (RPE), photoreceptors and periocular tis... Highest expression in Colon Transverse (30.7 TPM) and Small Intestine Terminal Ileum (15.4 TPM).
Acrocapitofemoral dysplasia is associated with mutations in the IHH gene on chromosome 2.
The IHH protein participates in IHH gene transcription is stimulated by RUNX2 pathway.
IHH is classified as a druggable target (Druggable Genome and Protease categories) with score 5.0.
Genetic testing for IHH is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 9 always present features, 4 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for acrocapitofemoral dysplasia.
4 publications have been identified in PubMed for acrocapitofemoral dysplasia. Research spans Review / Meta-Analysis (25%), Case Report / Case Series (25%), and Basic Science / Preclinical (25%).
Njie R (2025). [PMID: 40857061](https://pubmed.ncbi.nlm.nih.gov/40857061/). *Journal of cellular and molecular medicine*. [Review / Meta-Analysis]
Nair P (2025). [PMID: 40771183](https://pubmed.ncbi.nlm.nih.gov/40771183/). *Molecular syndromology*. [Case Report / Case Series]
Saeed T (2025). [PMID: 40045933](https://pubmed.ncbi.nlm.nih.gov/40045933/). *Molecular genetics & genomic medicine*. [Gene Therapy / Novel Therapeutics]
Zhu T (2025). [PMID: 40606564](https://pubmed.ncbi.nlm.nih.gov/40606564/). *Phenomics (Cham, Switzerland)*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 3:00 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acrocapitofemoral dysplasia
Arms and legs | 8 | Small finger, Cone-shaped epiphyses of the phalanges of the hand, Short distal phalanx of finger |
Growth and development | 2 | Short stature, Disproportionate short-limb short stature |
Skin | 2 | Broad nail, Short nail |
Head and neck | 1 | Relative macrocephaly |
Brain and nerves | 1 | Intellectual disability |
Age of onset: childhood.